Related Experiment Video
Updated: Jul 22, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity
Nature
|December 4, 1986
Summary
Researchers developed a new agent that mimics thyroid hormone T3 to lower cholesterol and improve liver function. This agent is less toxic than T3, offering a safer treatment for atherosclerosis.
Area of Science:
- Biochemistry
- Pharmacology
- Cardiovascular Medicine
Background:
- Thyroid hormone (T3) effectively lowers plasma cholesterol but carries significant cardiac risks.
- Atherosclerosis is a major cardiovascular disease characterized by plaque buildup in arteries, often linked to high cholesterol.
Purpose of the Study:
- To identify and characterize novel agents that mimic T3's cholesterol-lowering effects with reduced toxicity.
- To evaluate the therapeutic potential of a specific T3-mimicking agent for atherosclerosis treatment.
Main Methods:
- Synthesis and screening of T3-mimicking compounds.
- In vitro and in vivo studies to assess efficacy in reducing cholesterol and stimulating liver function.
- Cardiovascular safety profiling of the lead compound.
Main Results:
- One novel agent demonstrated efficacy comparable to T3 in reducing plasma cholesterol levels.
- The agent significantly stimulated liver function markers.
- Crucially, the agent exhibited minimal impact on cardiac function, suggesting a reduced toxicity profile.
Conclusions:
- A novel T3-mimicking agent offers a promising therapeutic strategy for managing hypercholesterolemia.
- This agent presents a safer alternative to T3 for treating conditions like atherosclerosis due to its improved cardiac safety profile.
Related Concept Videos
01:27Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...